Report
Alpesh Mehta

MOSL: PIRAMAL ENTERPRISES (Buy)-Builds up a head of steam in Financial Services

PIRAMAL ENTERPRISES: Builds up a head of steam in Financial Services; Focus more on profitability than growth; looks to be among top 10 HFCs

(PIEL IN, Mkt Cap USD8.2b, CMP INR3202, TP INR3685, 15% Upside, Buy)

 

  • Piramal Enterprises (PIEL) hosted an analyst meet to discuss its Financial Services business in detail. Management believes that opportunities in corporate lending are aplenty, given that most public sector banks and some private sector banks are not so active in this space. Hence, while bulk of its loan book (~75%) is wholesale real estate lending, management expects the share of non-real estate corporate lending to expand meaningfully over the next three years.
  • Before investing/lending in any segment, the company does a deep study of the sector, which usually takes around six months. To the company's advantage, several executives in the corporate lending team have good working experience in the respective industries. In addition, what differentiates PIEL from its peers is that its legal team is hands-on - it is involved in a transaction right from the start (structuring, etc.) and is not merely involved in documentation and other administrative tasks.
  • Management has a clear intention to generate at least 20% RoE across businesses over the long term. PIEL does not have any 'growth' targets for its executives - the only targets are on RoE/profitability and asset quality.
  • With a favorable operating environment (waning competition from PSU banks, better transparency due to RERA, etc.), strong management at helm of affairs and adequate capital, we believe PIEL is well poised to capture the growth opportunities that exist in the wholesale lending space. The company has demonstrated its track record of delivering value to shareholders across businesses. With a confluence of factors working to PIEL's advantage, we upgrade our FY19/20 EPS estimates by up to 4% (to factor in better growth) and roll over our SOTP to Sept'20. With better growth, we have also increased the multiple for the Financial Services business to 3.2x from 3x earlier. Our revised SOTP-based TP is INR3,685. Buy.
Underlying
Piramal Enterprises Ltd.

Piramal Enterprises is a pharmaceutical group based in India. Co. is engaged in the production, packaging, marketing, sale, import, and export of pharmaceutical products in the form of tablets, capsules, liquids, powders, creams, ointments, granules and bulk drug. Co. is engaged in the manufacture of glass containers. Co.'s brands include Phensedyl, Haemaccel, Stemetil, Paraxin, Phenergan, Gardenal, Pentids, Tixylix, Supradyn and Tenormin. Co. maintains over 295 issued patents plus 808 pending patent applications, spread across categories such as compositions of matter, methods of treatments, biomarkers, diagnostics, pharmaceutical compositions and drug delivery systems.

Provider
Motilal Oswal
Motilal Oswal

​Motilal Oswal Financial Services Ltd. is a reputed name in Financial Services and Online Trading with group companies providing services such as Private Wealth Management, Retail Broking and Distribution, Institutional Broking, Asset Management, Investment Banking, Private Equity, Commodity Broking, Currency Broking, Principal Strategies & Home Finance. 

Motilal Oswal Securities is a group company of Motilal Oswal Financial Service Limited which started as a stock trading company and has blossomed into well diversified firm offering a range of financial products and services. Motilal Oswal has built a reputation as the source for best stock trading company and this has taken a wealth of experience, knowledge and expertise, constantly working in tandem, over the years.

Analysts
Alpesh Mehta

Other Reports on these Companies
Other Reports from Motilal Oswal

ResearchPool Subscriptions

Get the most out of your insights

Get in touch